Burning Rock Biotech Limited American Depositary Receipt (BNR) at a glance

Burning Rock Biotech Limited American Depositary Receipt (BNR) is a micro-cap Healthcare company. It trades at $10.07, with a -11.5% profit margin and revenue decline of 18.9%. It does not pay a dividend. Vestovix scores it 35/100 overall. Its strongest dimension is Value (48/100) and its weakest is Growth (21/100). It carries above-market volatility, so expect larger swings.

Price

$10.07

Market cap

$90.6M

P/E ratio

n/a

Dividend yield

None

Beta

1.32

52-week range

$4.75 to $41.72